Xinhua Zhao
Profile
Dr. Xinhua Zhao is Senior Scientist at Solazyme, Inc.
Dr. Zhao was previously employed as Senior Research Scientist by AureoGen Biosciences, Inc.
He received his graduate degree from Zhejiang University and a doctorate degree from Purdue University.
Former positions of Xinhua Zhao
| Companies | Position | End |
|---|---|---|
| TERRAVIA HOLDINGS INC | Chief Tech/Sci/R&D Officer | - |
AureoGen, Inc.
 AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Private Equity Analyst | 2010-02-03 |
Training of Xinhua Zhao
| Zhejiang University | Graduate Degree |
| Purdue University | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
AureoGen, Inc.
AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Health Technology |
TerraVia Holdings, Inc.
 TerraVia Holdings, Inc. Household/Personal CareConsumer Non-Durables TerraVia Holdings, Inc. engaged in the production of food, nutrition, and specialty ingredients from algae. It produced oils, specialty fats, and powdered ingredients using its microalgae-based technology platform. The company was founded by Jonathan S. Wolfson and Harrison F. Dillon on March 31, 2003 and was headquartered in San Francisco, CA. | Consumer Non-Durables |
- Stock Market
- Insiders
- Xinhua Zhao
